SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

57.79

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	103.60	136.80	176.83	218.37	210.05	276.61
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	103.60	136.80	176.83	218.37	210.05	276.61
Other Income	4.19	9.57	0.24	1.26	6.08	6.54
Stock Adjustments	1.79	18.07	-62.63	-0.49	-4.31	4.87
Total Income	109.58	164.44	114.44	219.14	211.82	288.02
EXPENDITURE :
Raw Materials	60.12	85.39	206.00	142.92	92.76	155.17
Power & Fuel Cost	3.48	4.87	8.73	7.55	9.02	8.99
Employee Cost	23.04	29.45	29.67	31.68	26.45	31.87
Other Manufacturing Expenses	6.22	10.26	19.42	17.65	18.98	16.08
Selling & Administrative Expenses	27.03	25.87	37.65	26.70	30.76	28.89
Miscellaneous Expenses	0.00	32.17	0.63	0.42	-0.07	7.75
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	119.90	188.00	302.10	226.92	177.91	248.74
Operating Profit	-10.33	-23.56	-187.67	-7.78	33.91	39.27
Interest	2.54	2.41	35.55	39.71	41.63	43.44
Gross Profit	-12.87	-25.97	-223.22	-47.49	-7.72	-4.17
Depreciation	18.63	18.41	106.91	17.45	15.80	16.57
Profit Before Tax	-31.50	-44.38	-330.13	-64.94	-23.52	-20.74
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	-2.12	2.82	-0.23	-1.57
Reported Net Profit	-31.50	-44.38	-328.01	-67.75	-23.28	-19.17
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	-6.87
Adjusted Net Profit	-31.50	-44.38	-328.01	-67.75	-23.28	-12.30
Adjustment below Net Profit	0.58	0.48	4.05	0.56	-6.14	-0.50
P & L Balance brought forward	-160.33	-116.42	207.54	274.73	304.15	323.82
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-191.25	-160.33	-116.42	207.54	274.73	304.15
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-3.80	-5.35	-39.56	-8.17	-2.81	-2.31
Earnings Per Share(Adj)-Unit Curr	-3.80	-5.35	-39.56	-8.17	-2.81	-2.31
Book Value-Unit Curr	2.47	6.20	11.50	50.57	58.67	62.22
Book Value(Adj)-Unit Curr	2.47	6.20	11.50	50.57	58.67	62.22

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)